Yvonne E. Chiu, MD

Publications

• Lipofibromatosis-like neural tumors: Report of a case and review of 73 reported cases.

  (Ulschmid CM, Singam V, Segura A, Gourlay DM, Chiu YE.) Pediatr Dermatol. 2023 Jan 08 PMID: 36617686 SCOPUS ID: 2-s2.0-85146077982 01/10/2023

• Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.

  (Ezeh N, Ardalan K, Buhr KA, Nguyen C, Al Ahmed O, Ardoin SP, Barton V, Bell S, Brandling-Bennett H, Castelo-Soccio L, Chiu YE, Chong BF, Co DO, Lara-Corrales I, Cintosun A, Curran ML, Diaz LZ, Elman SA, Faith EF, Garcia-Romero MT, Grossman-Kranseler J, Hogeling M, Hudson AD, Hunt RD, Ibler EM, Marques MC, Monir RL, Oza V, Paller AS, Putterman E, Rodriguez-Salgado P, Schoch JJ, Truong A, Wang J, Lee LW, Vleugels RA, Klein-Gitelman MS, von Scheven E, Werth VP, Arkin LM.) J Am Acad Dermatol. 2022 Sep;87(3):559-566 PMID: 35487332 SCOPUS ID: 2-s2.0-85130970757 04/30/2022

• Scalloped Ulcerations in a Tattoo.

  (Tjahjono L, Chiu YE.) J Pediatr. 2022 Aug;247:174-175 PMID: 35390348 04/08/2022

• Systemic lupus erythematosus in a 15-year-old with graft-versus-host disease following liver transplant and unexpected full hematopoietic engraftment.

  (Goeser LE, Chiu YE, Lerret SM, Nocton JJ.) JAAD Case Rep. 2022 Jun;24:4-7 PMID: 35518274 PMCID: PMC9062762 SCOPUS ID: 2-s2.0-85129442266 05/07/2022

• Undiagnosed and Rare Diseases in Critical Care: Severe Mucocutaneous Medication Reactions.

  (Shields BE, Wanat KA, Chiu YE.) Crit Care Clin. 2022 Apr;38(2):243-269 PMID: 35369946 SCOPUS ID: 2-s2.0-85127353227 04/05/2022

• Vulvar aphthous ulcer after COVID-19 vaccination.

  (Popatia S, Chiu YE.) Pediatr Dermatol. 2022 Jan;39(1):153-154 PMID: 34888935 SCOPUS ID: 2-s2.0-85120880880 12/11/2021

• A skin-colored sacral papule.

  (Ng A, Wanat KA, Chiu YE.) Pediatr Dermatol. 2021 Sep;38(5):1312-1314 PMID: 34750879 SCOPUS ID: 2-s2.0-85118756022 11/10/2021

• Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease.

  (Sink JR, Chiu YE.) Pediatr Dermatol. 2021 Sep;38(5):1020-1031 PMID: 34272748 SCOPUS ID: 2-s2.0-85110352628 07/18/2021

• Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.

  (Munshi MA, Noe MH, Chiu YE, Streicher JL.) Pediatr Dermatol. 2021 Sep;38(5):1040-1046 PMID: 34060143 PMCID: PMC8578306 SCOPUS ID: 2-s2.0-85107285725 06/02/2021

• Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations.

  (Chiu YE, Shmuylovich L, Kiguradze T, Anderson K, Sibbald C, Tollefson M, Kunzler E, Tom WL, Bond K, Ahmad RC, Garcia-Romero MT, Irfan M, Kollman K, Hunt R, Stein SL, Arkin L, Wong V, Pope E, Jacobe H, Brandling-Bennett HA, Cordoro KM, Bercovitch L, Rangel SM, Liu X, Szabo A, Paller AS.) J Am Acad Dermatol. 2021 Jul;85(1):38-45 PMID: 33689776 SCOPUS ID: 2-s2.0-85103699225 03/11/2021

• Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients.

  (Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G, Arnold JD, Sprague J, Nguyen H, Wan S, Atenafu EG, Pope E, Hamilton J, Naik HB, Lara-Corrales I.) JAMA Dermatol. 2021 Apr 01;157(4):385-391 PMID: 33625473 PMCID: PMC7905696 SCOPUS ID: 2-s2.0-85101680713 02/25/2021

• Clinical characteristics and management of clinically amyopathic juvenile dermatomyositis across four academic centers

  (Bradley F, Bayer ML, Co DO, Chiu Y, Huber AM, Ahmad RC, Baris HE, Oberle EJ, Kim S.) Pediatric Dermatology. March/April 2021;38(2):413-419 SCOPUS ID: 2-s2.0-85099405741 03/01/2021